<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599812438842</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599812438842</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Sinonasal Disorders</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Syndrome of Inappropriate Antidiuretic Hormone Secretion in Patients with Olfactory Neuroblastoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gray</surname><given-names>Stacey T.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812438842">1</xref>
<xref ref-type="aff" rid="aff2-0194599812438842">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Holbrook</surname><given-names>Eric H.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812438842">1</xref>
<xref ref-type="aff" rid="aff2-0194599812438842">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Najm</surname><given-names>Mohammed H.</given-names></name>
<xref ref-type="aff" rid="aff3-0194599812438842">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sadow</surname><given-names>Peter M.</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0194599812438842">1</xref>
<xref ref-type="aff" rid="aff2-0194599812438842">2</xref>
<xref ref-type="aff" rid="aff4-0194599812438842">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Curry</surname><given-names>William T.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0194599812438842">2</xref>
<xref ref-type="aff" rid="aff5-0194599812438842">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lin</surname><given-names>Derrick T.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599812438842">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599812438842"><label>1</label>Department of Otolaryngology–Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA</aff>
<aff id="aff2-0194599812438842"><label>2</label>Harvard Medical School, Boston, Massachusetts, USA</aff>
<aff id="aff3-0194599812438842"><label>3</label>Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts, USA</aff>
<aff id="aff4-0194599812438842"><label>4</label>Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA</aff>
<aff id="aff5-0194599812438842"><label>5</label>Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA</aff>
<author-notes>
<corresp id="corresp1-0194599812438842">Stacey T. Gray, MD, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA Email: <email>Stacey_gray@meei.harvard.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2012</year>
</pub-date>
<volume>147</volume>
<issue>1</issue>
<fpage>147</fpage>
<lpage>151</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>11</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>9</day>
<month>12</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>1</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0194599812438842">
<title>Objective</title>
<p>The syndrome of inappropriate antidiuretic hormone secretion (SIADH) has been reported as a paraneoplastic syndrome in many different types of malignancies. Several case reports of SIADH have been reported in patients with olfactory neuroblastoma (ONB), but the exact incidence is unknown. The purpose of this study was to review our experience with olfactory neuroblastoma and to identify all patients who had a history of SIADH prior to the diagnosis of ONB.</p>
</sec>
<sec id="section2-0194599812438842">
<title>Study Design</title>
<p>Case series and chart review</p>
</sec>
<sec id="section3-0194599812438842">
<title>Setting</title>
<p>Tertiary care university-affiliated medical center.</p>
</sec>
<sec id="section4-0194599812438842">
<title>Subjects and Methods</title>
<p>A total of 21 patients presented to our institution with ONB between 1997 and 2009. All records were reviewed for a history of preoperative hyponatremia or SIADH.</p>
</sec>
<sec id="section5-0194599812438842">
<title>Results</title>
<p>Three patients were identified who had a history of SIADH prior to the diagnosis of ONB. Immunohistochemical staining of the tumor specimens from the 3 patients with SIADH was positive for arginine vasopressin. SIADH resolved in all 3 patients after successful treatment of ONB.</p>
</sec>
<sec id="section6-0194599812438842">
<title>Conclusion</title>
<p>Although uncommon, SIADH can be the presenting symptom of ONB and should be considered during the workup for idiopathic SIADH.</p>
</sec>
</abstract>
<kwd-group>
<kwd>olfactory neuroblastoma</kwd>
<kwd>syndrome of inappropriate antidiuretic hormone</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Olfactory neuroblastoma (ONB), first described by Berger et al in 1924,<sup><xref ref-type="bibr" rid="bibr1-0194599812438842">1</xref></sup> is a rare malignancy of the nasal cavity thought to arise from the olfactory epithelium. It represents approximately 2% of all sinonasal tumors.<sup><xref ref-type="bibr" rid="bibr2-0194599812438842">2</xref></sup> These tumors are believed to arise from neural crest cells of the upper nasal cavity.<sup><xref ref-type="bibr" rid="bibr3-0194599812438842">3</xref>,<xref ref-type="bibr" rid="bibr4-0194599812438842">4</xref></sup> This olfactory neuroepithelium, a columnar, serous, nonciliated cell type, is typically found in the cribriform plate but can also be found on the superior turbinates, middle turbinates, and upper nasal septum. The diagnosis of ONB is often delayed because many of the initial symptoms are nonspecific. The most common presenting symptoms are nasal obstruction and epistaxis, followed by headache, rhinorrhea, and anosmia.<sup><xref ref-type="bibr" rid="bibr2-0194599812438842">2</xref></sup></p>
<p>The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is defined as the presence of hyponatremia and hyposmolality in a patient with clinical euvolemia, inappropriate urinary concentration (greater than 100 mOsm/kg), and elevated urinary sodium (greater than 40 mmol/L) with a normal salt and water intake. Other causes of elevated ADH, such as adrenal failure, hypothyroidism, and diuretic use, should be excluded before confirming the diagnosis of SIADH.<sup><xref ref-type="bibr" rid="bibr5-0194599812438842">5</xref><xref ref-type="bibr" rid="bibr6-0194599812438842"/>-<xref ref-type="bibr" rid="bibr7-0194599812438842">7</xref></sup> The most common causes of SIADH are pulmonary disease (such as pneumonia), medications (such as antidepressants), intracranial pathology (such as traumatic brain injury or subarachnoid hemorrhage), and malignancy.<sup><xref ref-type="bibr" rid="bibr6-0194599812438842">6</xref>,<xref ref-type="bibr" rid="bibr8-0194599812438842">8</xref></sup></p>
<p>A paraneoplastic syndrome is a disorder caused by a malignancy that is not related to direct tumor invasion or metastasis. Paraneoplastic endocrine syndromes, such as SIADH, are thought to be due to tumor secretion of peptides or hormones. SIADH is seen as a paraneoplastic syndrome in 1% to 2% of all patients with cancer.<sup><xref ref-type="bibr" rid="bibr9-0194599812438842">9</xref></sup> It is most commonly reported in patients with small-cell carcinoma of the lung, where up to 15% of patients develop SIADH.<sup><xref ref-type="bibr" rid="bibr10-0194599812438842">10</xref></sup> Several authors have reported the incidence of SIADH in patients with head and neck cancer. Talmi et al<sup><xref ref-type="bibr" rid="bibr11-0194599812438842">11</xref></sup> presented the largest series in 1992; a retrospective review of 1,436 patients with head and neck cancer identified a 3% incidence of SIADH. A review of the literature, published in 1997, identified 70 cases of SIADH in patients with cancer of the head and neck, with the most common histologic tumor type being squamous cell carcinoma.<sup><xref ref-type="bibr" rid="bibr12-0194599812438842">12</xref></sup> SIADH has been reported in patients with several sinonasal malignancies, including sinonasal teratocarcinosarcoma<sup><xref ref-type="bibr" rid="bibr13-0194599812438842">13</xref></sup> and small-cell neuroendocrine carcinoma.<sup><xref ref-type="bibr" rid="bibr14-0194599812438842">14</xref>,<xref ref-type="bibr" rid="bibr15-0194599812438842">15</xref></sup> A review of the literature revealed 11 case reports of patients with ONB and SIADH.<sup><xref ref-type="bibr" rid="bibr16-0194599812438842">16</xref><xref ref-type="bibr" rid="bibr17-0194599812438842"/><xref ref-type="bibr" rid="bibr18-0194599812438842"/><xref ref-type="bibr" rid="bibr19-0194599812438842"/><xref ref-type="bibr" rid="bibr20-0194599812438842"/><xref ref-type="bibr" rid="bibr21-0194599812438842"/><xref ref-type="bibr" rid="bibr22-0194599812438842"/><xref ref-type="bibr" rid="bibr23-0194599812438842"/><xref ref-type="bibr" rid="bibr24-0194599812438842"/><xref ref-type="bibr" rid="bibr25-0194599812438842"/>-<xref ref-type="bibr" rid="bibr26-0194599812438842">26</xref></sup></p>
<p>The typical workup for unexplained SIADH often includes imaging of the lungs and brain. However, assessment for a sinonasal tumor is often not included in this workup because of the rarity of this entity. This can potentially lead to a delay in the diagnosis of ONB.</p>
<p>The purpose of this study was to review our experience with ONB and to specifically identify patients who had a history of SIADH prior to the diagnosis of ONB.</p>
<sec id="section7-0194599812438842" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>A retrospective chart review was performed of all patients with olfactory neuroblastoma presenting to the Massachusetts Eye and Ear Infirmary (MEEI) and Massachusetts General Hospital (MGH) from 1997 to 2009. Institutional review board (IRB) approval was obtained for this study from the MEEI IRB. Medical records were reviewed including presenting symptoms, staging, treatment, and outcome.</p>
<p>Paraffin blocks of ONB specimens were obtained from the MGH Pathology Department. The specimens were carefully cut at 6- to 8-µm thickness. Sections were collected on Plus slides (Fischer Scientific, Pittsburg, Pennsylvania) and warmed at 45°C for 24 hours. The slides were then immersed in xylene to remove the paraffin. The sections were then rehydrated by immersing in sequential dilutions of ethanol. Hydrogen peroxide (1%) was used to quench inherent peroxidase activity. Sections were then covered with 0.01 M citric acid buffer (pH 6.0) and placed in a commercial food steamer containing water in its reservoir for 10 minutes. They were then rinsed in phosphate-buffered saline (PBS) and then incubated in a blocking solution (5% nonfat dry milk/4% bovine serum albumin in PBS with 10% donkey serum) for 10 minutes. The sections were then incubated with a rabbit polyclonal antibody against arginine vasopressin (Millipore catalog no. AB1565) at a concentration of 1:5000 and mixed with 0.1% Triton X-100 in blocking solution overnight at 4°C. Bound primary antibodies were then visualized by incubation with biotinylated donkey antirabbit (Jackson ImmunoResearch Laboratories Inc, West Grove, Pennsylvania), followed by avidin-biotinylated HRP conjugate (Elite ABC Kit; Vector Laboratory, Burlingame, California) using 3,3′-diamino-benzidine as a chromagen. Sections were counterstained with hematoxylin and eosin then coverslipped using DPX mounting media.</p>
</sec>
<sec id="section8-0194599812438842" sec-type="results">
<title>Results</title>
<p>Twenty-one patients were identified. There were 11 male and 10 female patients. The average age at presentation was 47 years. Thirteen patients were Kadish Stage C, and 8 patients were Kadish Stage B at presentation. Two patients had cervical disease at the time of presentation.</p>
<p>The current treatment protocol for ONB at our institution consists of surgical resection via anterior craniofacial resection followed by postoperative proton beam radiation therapy. Chemotherapy is reserved for patients with a positive margin or Kadish C staging.<sup><xref ref-type="bibr" rid="bibr27-0194599812438842">27</xref></sup> Mean follow-up time for all patients was 55 months. Four recurrences have been documented. Three patients are currently alive with disease, and 1 patient died of disease.</p>
<p>The medical records for all patients with olfactory neuroblastoma were reviewed for any history of hyponatremia, and all sodium levels at the time of presentation were reviewed. Three patients had a history of unexplained hyponatremia prior to the diagnosis of olfactory neuroblastoma and were diagnosed with SIADH. Further details about this subset of patients are available for review in <xref ref-type="table" rid="table1-0194599812438842"><bold>Table 1</bold></xref>. In all 3 cases, the hyponatremia occurred months to years prior to the eventual diagnosis of ONB. All 3 patients with SIADH had an episode of hyponatremia severe enough to cause mental status changes and require hospitalization. In all 3 cases, a cause of the hyponatremia was not identified, and the diagnosis of SIADH was given. All 3 patients were treated with water restriction, and their sodium levels improved but never completely normalized. For 2 of the patients, brain imaging was performed at the time of diagnosis of SIADH, and sinus disease was noted but was not recognized as a sinonasal tumor. For all 3 patients, worsening sinonasal complaints and eventual otolaryngology evaluation led to the diagnosis of ONB. All 3 patients were treated according to our standard protocol for ONB. Details of their individual therapy are available for review in <xref ref-type="table" rid="table1-0194599812438842"><bold>Table 1</bold></xref>. After surgical resection, the SIADH resolved in all 3 patients. Currently, all 3 patients have normal sodium levels and are not on any treatment for SIADH.</p>
<table-wrap id="table1-0194599812438842" position="float">
<label>Table 1.</label>
<caption>
<p>Patients Presenting with ONB and SIADH</p>
</caption>
<graphic alternate-form-of="table1-0194599812438842" xlink:href="10.1177_0194599812438842-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Case</th>
<th align="center">Age at Presentation, y</th>
<th align="center">Sex</th>
<th align="center">Time from Presentation of SIADH to Diagnosis of ONB</th>
<th align="center">Sodium Level at Time of Diagnosis of SIADH</th>
<th align="center">Kadish Stage</th>
<th align="center">Treatment</th>
<th align="center">Follow-up Time</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>29</td>
<td>Male</td>
<td>5 mo</td>
<td>114</td>
<td>C</td>
<td>Induction chemotherapy, CFR and neck dissection, postop chemoradiation</td>
<td>28 mo</td>
</tr>
<tr>
<td>2</td>
<td>25</td>
<td>Female</td>
<td>3 y</td>
<td>115</td>
<td>B</td>
<td>CFR, postop proton beam RT</td>
<td>23 mo</td>
</tr>
<tr>
<td>3</td>
<td>32</td>
<td>Female</td>
<td>8 mo</td>
<td>110</td>
<td>B</td>
<td>CFR, postop proton beam RT</td>
<td>29 mo</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0194599812438842">
<p>Abbreviations: CFR, craniofacial resection; ONB, olfactory neuroblastoma; RT, radiotherapy; SIADH, syndrome of inappropriate antidiuretic hormone secretion.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>All 3 patients were relatively young compared with the patients without SIADH (mean age 28 years vs 51 years for the entire group). They are all currently disease free with no statistically significant difference in overall survival or control compared with the patients without a history of SIADH. The mean follow-up time after treatment for these 3 patients was 27 months.</p>
<sec id="section9-0194599812438842">
<title>Immunohistochemical Staining</title>
<p>Immunohistochemical staining of the sections obtained from the 3 cases of ONB with SIADH were all positive for arginine vasopressin (<xref ref-type="fig" rid="fig1-0194599812438842"><bold>Figure 1</bold></xref>). Control sections were stained using an equal amount of rabbit serum in place of the vasopressin-specific antibody and resulted in the absence of staining (not shown). Sections obtained from a random selection of 3 ONB cases without SIADH were all negative for the vasopressin protein (<xref ref-type="fig" rid="fig1-0194599812438842"><bold>Figure 1</bold></xref>).</p>
<fig id="fig1-0194599812438842" position="float">
<label>Figure 1.</label>
<caption>
<p>(A) A typical example of olfactory neuroblastoma with pleomorphic, epithelioid cells with irregular, hyperchromatic nuclei and cleared-out cytoplasm in a vaguely nested pattern. Scant neural tissue is present (arrows), but no true neuropil is seen (Hyams grade III; hematoxylin and eosin, 20×). (B) Nests of submucosal olfactory neuroblastoma, grade 3, with strong cytoplasmic staining in a dotlike pattern for vasopressin (arrowheads). Note the overlying negative, ciliated columnar epithelial surface (S; vasopressin immunoperoxidase, 20×). (C) Sheetlike high-powered stain of olfactory neuroblastoma, grade 3. Mitoses are seen (arrows), but this representative section from a patient without syndrome of inappropriate antidiuretic hormone secretion shows absence of vasopressin staining (vasopressin immunoperoxidase, 40×).</p>
</caption>
<graphic xlink:href="10.1177_0194599812438842-fig1.tif"/>
</fig>
</sec>
</sec>
<sec id="section10-0194599812438842" sec-type="discussion">
<title>Discussion</title>
<p>Schwartz et al<sup><xref ref-type="bibr" rid="bibr28-0194599812438842">28</xref></sup> was the first to describe SIADH in the setting of malignancy, specifically in 2 patients with bronchogenic carcinoma. The presumed mechanism of SIADH in the setting of malignancy has been the secretion of arginine vasopressin by the tumor.<sup><xref ref-type="bibr" rid="bibr5-0194599812438842">5</xref></sup> All 3 of our patients had complete resolution of their SIADH after surgical resection, supporting the idea that tumor secretion of vasopressin is responsible for SIADH.</p>
<p>Immunohistochemical staining for arginine vasopressin was positive in our 3 patients with ONB with SIADH, in contrast to negative results in 3 randomly selected patients with ONB without SIADH, further supporting vasopressin production by the tumor as the mechanism of SIADH in these patients. Although the histopathology of these 3 tumors was similar to the group, the presence of vasopressin is different. It was not seen in patients without SIADH.</p>
<p>With a relatively uniform treatment algorithm, there was no difference in local control or overall survival in patients without SIADH versus patients with SIADH. However, it must be stated that this represents a small number of patients, and the follow-up time is short. Continued follow-up will be necessary. Interestingly, sodium levels could be considered a tumor marker in these patients and should likely be used as part of routine follow-up. A case has been reported of hyponatremia being the presenting symptom of recurrent ONB.<sup><xref ref-type="bibr" rid="bibr25-0194599812438842">25</xref></sup></p>
<p>In a review of the literature, we identified 11 case reports of patients with ONB presenting with SIADH (<xref ref-type="table" rid="table1-0194599812438842"><bold>Table 1</bold></xref>).<sup><xref ref-type="bibr" rid="bibr16-0194599812438842">16</xref><xref ref-type="bibr" rid="bibr17-0194599812438842"/><xref ref-type="bibr" rid="bibr18-0194599812438842"/><xref ref-type="bibr" rid="bibr19-0194599812438842"/><xref ref-type="bibr" rid="bibr20-0194599812438842"/><xref ref-type="bibr" rid="bibr21-0194599812438842"/><xref ref-type="bibr" rid="bibr22-0194599812438842"/><xref ref-type="bibr" rid="bibr23-0194599812438842"/><xref ref-type="bibr" rid="bibr24-0194599812438842"/><xref ref-type="bibr" rid="bibr25-0194599812438842"/>-<xref ref-type="bibr" rid="bibr26-0194599812438842">26</xref></sup> Interestingly, 8 of the 11 reported cases were younger than 35 years. In our series, we identified 3 patients of 21 with ONB who had a history of SIADH prior to the diagnosis of ONB. Our 3 patients tended to be younger in age (average age of 28 years for these 3 patients vs an average age of 51 years for the entire group). All 3 patients had an episode of severe symptomatic hyponatremia requiring emergency room evaluation. All 3 of our patients were diagnosed months to years prior to the diagnosis of ONB. This was also the case in several of the previously noted case reports, in which patients had been diagnosed with SIADH for several years prior to the discovery of ONB.<sup><xref ref-type="bibr" rid="bibr17-0194599812438842">17</xref>,<xref ref-type="bibr" rid="bibr26-0194599812438842">26</xref></sup></p>
<p>The causes of SIADH are quite varied. The initial workup for idiopathic SIADH often involves imaging studies to assess for pulmonary and intracranial disease. Two of our patients had imaging studies of the head performed at the time of initial hyponatremia and were incidentally noted to have sinus disease (based on a review of records from outside institutions); however, these abnormalities were not recognized as a tumor. This is likely because the association between sinonasal tumors and SIADH is not commonly reported. Increased awareness of this possibility would likely lead to more scrutiny of sinonasal abnormalities during the workup of idiopathic SIADH, especially since brain imaging is already being performed frequently. This should be particularly considered in young patients without another known cause for SIADH.</p>
</sec>
<sec id="section11-0194599812438842">
<title>Author Contributions</title>
<p><bold>Stacey T. Gray</bold>, substantial contribution to conception and design, acquisition of data, analysis and interpretation of data, drafting and revising the article, final approval; <bold>Eric H. Holbrook</bold>, assistance with acquisition and interpretation of data, revising the article, final approval; <bold>Mohammed H. Najm</bold>, assistance with acquisition of data, revising the article, final approval; <bold>Peter M. Sadow</bold>, assistance with analysis and interpretation of data, revising the article, final approval; <bold>William T. Curry</bold>, assistance with acquisition and interpretation of data, revising the article, final approval; <bold>Derrick T. Lin</bold>, substantial contribution to conception and design, acquisition of data, analysis and interpretation of data, drafting and revising the article, final approval.</p>
</sec>
<sec id="section12-0194599812438842">
<title>Disclosures</title>
<p><bold>Competing interests:</bold> Derrick T. Lin was a one-time consultant for Medtronic.</p>
<p><bold>Sponsorships:</bold> None.</p>
<p><bold>Funding source:</bold> None.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</p>
<p>This article was presented at the North American Skull Base Society meeting in Scottsdale, Arizona, February 2011.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599812438842">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berger</surname><given-names>L</given-names></name>
<name><surname>Luc</surname><given-names>R</given-names></name>
<name><surname>Richard</surname><given-names>D</given-names></name>
</person-group>. <article-title>L’estherioneuroepitheliome olfactif</article-title>. <source>Bull Assoc Fr Etude Cancer</source>. <year>1924</year>;<volume>13</volume>:<fpage>410</fpage>-<lpage>421</lpage>.</citation>
</ref>
<ref id="bibr2-0194599812438842">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>LD</given-names></name>
</person-group>. <article-title>Olfactory neuroblastoma</article-title>. <source>Head Neck Pathol</source>. <year>2009</year>;<volume>3</volume>(<issue>3</issue>):<fpage>252</fpage>-<lpage>259</lpage>.</citation>
</ref>
<ref id="bibr3-0194599812438842">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dulguerov</surname><given-names>P</given-names></name>
<name><surname>Allal</surname><given-names>AS</given-names></name>
<name><surname>Calcaterra</surname><given-names>TC</given-names></name>
</person-group>. <article-title>Esthesioneuroblastoma: meta-analysis and review</article-title>. <source>Lancet Oncol</source>. <year>2001</year>;<volume>2</volume>:<fpage>683</fpage>-<lpage>690</lpage>.</citation>
</ref>
<ref id="bibr4-0194599812438842">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holbrook</surname><given-names>EH</given-names></name>
<name><surname>Wu</surname><given-names>E</given-names></name>
<name><surname>Curry</surname><given-names>WT</given-names></name>
<name><surname>Lin</surname><given-names>DT</given-names></name>
<name><surname>Schowb</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Immunohistochemical characterization of human olfactory tissue</article-title>. <source>Laryngoscope</source>. <year>2011</year>;<volume>121</volume>(<issue>8</issue>):<fpage>1687</fpage>-<lpage>1701</lpage>.</citation>
</ref>
<ref id="bibr5-0194599812438842">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baylis</surname><given-names>PH</given-names></name>
</person-group>. <article-title>The syndrome of inappropriate antidiuretic hormone secretion</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2003</year>;<volume>35</volume>:<fpage>1495</fpage>-<lpage>1499</lpage>.</citation>
</ref>
<ref id="bibr6-0194599812438842">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hannon</surname><given-names>MJ</given-names></name>
<name><surname>Thompson</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>The syndrome of inappropriate antidiuretice hormone: prevalence, causes and consequences</article-title> <source>Eur J Endocrinol</source>. <year>2010</year>;<volume>162</volume>:<fpage>S5</fpage>-<lpage>S12</lpage>.</citation>
</ref>
<ref id="bibr7-0194599812438842">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellison</surname><given-names>DH</given-names></name>
<name><surname>Berl</surname><given-names>T</given-names></name>
</person-group>. <article-title>The syndrome of inappropriate antidiuresis</article-title>. <source>N Engl J Med</source>. <year>2007</year>;<volume>356</volume>:<fpage>2064</fpage>-<lpage>2072</lpage>.</citation>
</ref>
<ref id="bibr8-0194599812438842">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fenske</surname><given-names>W</given-names></name>
<name><surname>Allolio</surname><given-names>B</given-names></name>
</person-group>. <article-title>The syndrome of inappropriate secretion of antidiuretic hormone: diagnostic and therapeutic advances</article-title>. <source>Horm Metab Res</source>. <year>2010</year>;<volume>42</volume>(<issue>10</issue>):<fpage>691</fpage>-<lpage>702</lpage>.</citation>
</ref>
<ref id="bibr9-0194599812438842">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pelosof</surname><given-names>LC</given-names></name>
<name><surname>Gerber</surname><given-names>DE</given-names></name>
</person-group>. <article-title>Paraneoplastic syndromes: an approach to diagnosis and treatment</article-title>. <source>Mayo Clin Proc</source>. <year>2010</year>;<volume>85</volume>(<issue>9</issue>):<fpage>838</fpage>-<lpage>854</lpage>.</citation>
</ref>
<ref id="bibr10-0194599812438842">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sorensen</surname><given-names>JB</given-names></name>
<name><surname>Anderson</surname><given-names>MK</given-names></name>
<name><surname>Hansen</surname><given-names>HH</given-names></name>
</person-group>. <article-title>Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease</article-title>. <source>J Intern Med</source>. <year>1995</year>;<volume>238</volume>:<fpage>97</fpage>-<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr11-0194599812438842">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Talmi</surname><given-names>YP</given-names></name>
<name><surname>Hoffman</surname><given-names>HT</given-names></name>
<name><surname>McCabe</surname><given-names>BF</given-names></name>
</person-group>. <article-title>Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck</article-title>. <source>Ann Otol Rhinol Laryngol</source>. <year>1992</year>;<volume>101</volume>(<issue>11</issue>):<fpage>964</fpage>-<lpage>969</lpage>.</citation>
</ref>
<ref id="bibr12-0194599812438842">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferlito</surname><given-names>A</given-names></name>
<name><surname>Rinaldo</surname><given-names>A</given-names></name>
<name><surname>Devaney</surname><given-names>KO</given-names></name>
</person-group>. <article-title>Syndrome of inappropriate antidiuretic hormone secretion associated with head and neck cancers: review of the literature</article-title>. <source>Ann Otol Rhinol Laryngol</source>. <year>1997</year>;<volume>106</volume>(<issue>10 pt 1</issue>):<fpage>878</fpage>-<lpage>883</lpage>.</citation>
</ref>
<ref id="bibr13-0194599812438842">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kleinschmidt-DeMasters</surname><given-names>BK</given-names></name>
<name><surname>Pflaumer</surname><given-names>SM</given-names></name>
<name><surname>Mulgrew</surname><given-names>TD</given-names></name>
<etal/>
</person-group>. <article-title>Sinonasal teratocarcinosarcom (“mixed olfactory neuroblastoma-craniopharyngioma”) presenting with syndrome of inappropriate secretion of antidiuretic hormone</article-title>. <source>Clin Neuropathol</source>. <year>2000</year>;<volume>19</volume>(<issue>2</issue>):<fpage>63</fpage>-<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr14-0194599812438842">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ma</surname><given-names>AT</given-names></name>
<name><surname>Lei</surname><given-names>KI</given-names></name>
</person-group>. <article-title>Small cell neuroendocrine carcinoma of the ethmoid sinuses presenting with generalized seizure and syndrome of inappropriate antidiuretic hormone secretion: a case report and review of literature</article-title>. <source>Am J Otolaryngol</source>. <year>2009</year>;<volume>30</volume>(<issue>1</issue>):<fpage>54</fpage>-<lpage>57</lpage>.</citation>
</ref>
<ref id="bibr15-0194599812438842">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vasan</surname><given-names>NR</given-names></name>
<name><surname>Medina</surname><given-names>JE</given-names></name>
<name><surname>Canfield</surname><given-names>VA</given-names></name>
<etal/>
</person-group>. <article-title>Sinonasal neuroendocrine carcinoma in association with SIADH</article-title>. <source>Head Neck</source>. <year>2004</year>;<volume>26</volume>(<issue>1</issue>):<fpage>89</fpage>-<lpage>93</lpage>.</citation>
</ref>
<ref id="bibr16-0194599812438842">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>W</given-names></name>
<name><surname>Ramage</surname><given-names>C</given-names></name>
<name><surname>Best</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>Nasal neuroblastoma secreting vasopressin: a case report</article-title>. <source>Cancer</source>. <year>1980</year>;<volume>45</volume>(<issue>5</issue>):<fpage>961</fpage>-<lpage>966</lpage>.</citation>
</ref>
<ref id="bibr17-0194599812438842">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Srigley</surname><given-names>JR</given-names></name>
<name><surname>Dayal</surname><given-names>VS</given-names></name>
<name><surname>Gregor</surname><given-names>RT</given-names></name>
<etal/>
</person-group>. <article-title>Hyponatremia secondary to olfactory neuroblastoma</article-title>. <source>Arch Otolaryngol</source>. <year>1983</year>;<volume>109</volume>(<issue>8</issue>):<fpage>449</fpage>-<lpage>462</lpage>.</citation>
</ref>
<ref id="bibr18-0194599812438842">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cullen</surname><given-names>MJ</given-names></name>
<name><surname>Cusack</surname><given-names>DA</given-names></name>
<name><surname>O’Briain</surname><given-names>DS</given-names></name>
<etal/>
</person-group>. <article-title>Neurosecretion of arginine vasopression by an olfactory neuroblastoma causing reversible syndrome of antidiuresis</article-title>. <source>Am J Med</source>. <year>1986</year>;<volume>81</volume>(<issue>5</issue>):<fpage>911</fpage>-<lpage>916</lpage>.</citation>
</ref>
<ref id="bibr19-0194599812438842">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Osterman</surname><given-names>J</given-names></name>
<name><surname>Calhoun</surname><given-names>A</given-names></name>
<name><surname>Dunham</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Chronic syndrome of inappropriate antidiuretic hormone secretion and hypertension in a patient with olfactory neuroblastoma: evidence of ectopic production of arginine vasopressin by the tumor</article-title>. <source>Arch Intern Med</source>. <year>1986</year>;<volume>146</volume>(<issue>9</issue>):<fpage>1731</fpage>-<lpage>1735</lpage>.</citation>
</ref>
<ref id="bibr20-0194599812438842">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Myers</surname><given-names>SL</given-names></name>
<name><surname>Hardy</surname><given-names>DA</given-names></name>
<name><surname>Wiebe</surname><given-names>CB</given-names></name>
<etal/>
</person-group>. <article-title>Olfactory neuroblastoma invading the oral cavity in a patient with inappropriate antidiuretic hormone secretion</article-title>. <source>Oral Surg Oral Med Oral Pathol</source>. <year>1994</year>;<volume>77</volume>(<issue>6</issue>):<fpage>645</fpage>-<lpage>650</lpage>.</citation>
</ref>
<ref id="bibr21-0194599812438842">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>al Ahwal</surname><given-names>M</given-names></name>
<name><surname>Jha</surname><given-names>N</given-names></name>
<name><surname>Nabholtz</surname><given-names>JM</given-names></name>
<etal/>
</person-group>. <article-title>Olfactory neuroblastoma: report of a case associated with inappropriate antidiuretic hormone secretion</article-title>. <source>J Otolaryngol</source>. <year>1994</year>;<volume>23</volume>(<issue>6</issue>):<fpage>437</fpage>-<lpage>439</lpage>.</citation>
</ref>
<ref id="bibr22-0194599812438842">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bernard</surname><given-names>P</given-names></name>
<name><surname>Bitrey</surname><given-names>D</given-names></name>
<name><surname>Boursier</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Olfactory esthesioneuroma manifesting as Schwartz-Batter syndrome</article-title>. <source>Rev Med Interne</source>. <year>2000</year>;<volume>21</volume>(<issue>3</issue>):<fpage>278</fpage>-<lpage>281</lpage>.</citation>
</ref>
<ref id="bibr23-0194599812438842">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muller</surname><given-names>MB</given-names></name>
<name><surname>Landgraf</surname><given-names>R</given-names></name>
<name><surname>Keck</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization</article-title>. <source>Biol Psychiatry</source>. <year>2000</year>;<volume>48</volume>(<issue>4</issue>):<fpage>330</fpage>-<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr24-0194599812438842">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miura</surname><given-names>K</given-names></name>
<name><surname>Mineta</surname><given-names>H</given-names></name>
<name><surname>Yokota</surname><given-names>N</given-names></name>
</person-group>. <article-title>Olfactory neuroblastoma with epithelial and endocrine differentiation transformed into ganglioneuroma after chemoradiotherapy</article-title>. <source>Pathol Int</source>. <year>2001</year>;<volume>51</volume>(<issue>12</issue>):<fpage>942</fpage>-<lpage>947</lpage>.</citation>
</ref>
<ref id="bibr25-0194599812438842">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Plasencia</surname><given-names>YL</given-names></name>
<name><surname>Cortes</surname><given-names>MB</given-names></name>
<name><surname>Arencibia</surname><given-names>DM</given-names></name>
<etal/>
</person-group>. <article-title>Esthesioneuroblastoma recurrence presenting as a syndrome of inappropriate antidiuretic hormone secretion</article-title>. <source>Head Neck</source>. <year>2006</year>;<volume>28</volume>(<issue>12</issue>):<fpage>1142</fpage>-<lpage>1146</lpage>.</citation>
</ref>
<ref id="bibr26-0194599812438842">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Renneboog</surname><given-names>B</given-names></name>
<name><surname>Decaux</surname><given-names>G</given-names></name>
</person-group>. <article-title>Idiopathic hyponatremia in a young patient: look at the sinus</article-title>. <source>Am J Med</source>. <year>2008</year>;<volume>121</volume>(<issue>5</issue>):<fpage>e5</fpage>-<lpage>e6</lpage>.</citation>
</ref>
<ref id="bibr27-0194599812438842">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nichols</surname><given-names>AC</given-names></name>
<name><surname>Chan</surname><given-names>AW</given-names></name>
<name><surname>Curry</surname><given-names>WT</given-names></name>
</person-group>. <article-title>Esthesioneuroblastoma: the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital experience with craniofacial resection, proton beam radiation and chemotherapy</article-title>. <source>Skull Base</source>. <year>2008</year>;<volume>18</volume>(<issue>5</issue>):<fpage>327</fpage>-<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr28-0194599812438842">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schwartz</surname><given-names>WB</given-names></name>
<name><surname>Bennett</surname><given-names>W</given-names></name>
<name><surname>Curelop</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone</article-title>. <source>Am J Med</source>. <year>1957</year>;<volume>23</volume>:<fpage>529</fpage>-<lpage>542</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>